Humacyte, Inc. Finance Lease, Liability
Humacyte, Inc. (HUMA) had Finance Lease, Liability of $29.40 million as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2026-03-27
- 2025-12-31: Finance Lease, Liability $29.40M.
- 2025-09-30: Finance Lease, Liability $29.82M.
- 2024-12-31: Finance Lease, Liability $16.50M; Finance Lease, Liability as first filed $16.54M.
- 2023-12-31: Finance Lease, Liability $18.90M; Finance Lease, Liability as first filed $18.85M.
| Period end | Finance Lease, Liability | Finance Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $29.40M 10-K · filed 2026-03-27 | |
| 2025-09-30 | $29.82M 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $16.50M 10-K · filed 2026-03-27 | $16.54M 10-K · filed 2025-03-31 |
| 2023-12-31 | $18.90M 10-K · filed 2025-03-31 | $18.85M 10-K · filed 2024-03-28 |
| 2022-12-31 | $21.10M 10-K · filed 2024-03-28 | $21.11M 10-K · filed 2023-03-24 |
| 2021-12-31 | $23.10M 10-K · filed 2023-03-24 | $23.09M 10-K · filed 2022-03-29 |
| 2020-12-31 | $24.80M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |